Yi Chen
Stock Analyst at HC Wainwright & Co.
(4.06)
# 541
Out of 5,113 analysts
450
Total ratings
43.39%
Success rate
15.43%
Average return
Main Sectors:
Stocks Rated by Yi Chen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LPCN Lipocine | Maintains: Buy | $7 → $15 | $10.91 | +37.49% | 6 | Jan 21, 2026 | |
| VRAX Virax Biolabs Group | Reiterates: Buy | $3 → $1 | $0.26 | +279.79% | 2 | Jan 9, 2026 | |
| GLSI Greenwich LifeSciences | Maintains: Buy | $39 → $50 | $25.47 | +96.31% | 9 | Dec 30, 2025 | |
| BLFS BioLife Solutions | Reiterates: Buy | $32 | $24.87 | +28.67% | 5 | Dec 29, 2025 | |
| LEXX Lexaria Bioscience | Maintains: Buy | $4 → $1.5 | $0.85 | +76.47% | 8 | Dec 26, 2025 | |
| BEAT HeartBeam | Maintains: Buy | $2.5 → $5.5 | $1.81 | +203.87% | 2 | Dec 10, 2025 | |
| OCUL Ocular Therapeutix | Maintains: Buy | $19 → $21 | $10.27 | +104.48% | 30 | Dec 8, 2025 | |
| AXGN Axogen | Maintains: Buy | $26 → $39 | $32.83 | +18.79% | 3 | Dec 5, 2025 | |
| BLTE Belite Bio | Maintains: Buy | $98 → $185 | $164.58 | +12.41% | 22 | Dec 1, 2025 | |
| BNGO Bionano Genomics | Maintains: Buy | $11 → $7 | $1.62 | +332.10% | 3 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $6.99 | +28.76% | 21 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $9 | $3.58 | +151.40% | 11 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2.5 → $1.5 | $0.28 | +431.91% | 4 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $7 | $1.77 | +295.48% | 1 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $0.72 | +454.79% | 14 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $54 → $36 | $21.75 | +65.52% | 6 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $64 → $69 | $44.47 | +55.16% | 7 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $42 | $27.15 | +54.70% | 17 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $98 → $89 | $65.32 | +36.25% | 3 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.45 | +244.83% | 2 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $17 | $16.98 | +0.12% | 20 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2 → $2.5 | $0.64 | +288.20% | 23 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $34 | $13.79 | +146.56% | 14 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.61 | - | 24 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.22 | +215.32% | 14 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $3.26 | +114.72% | 20 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $10 | $4.04 | +147.52% | 5 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.12 | +371.70% | 17 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $1.48 | +170.27% | 7 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $2.14 | +320.56% | 2 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $4.83 | +65.63% | 20 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $23 | $15.18 | +51.52% | 23 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $10.38 | +54.14% | 11 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $16.70 | +7.78% | 1 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $25 | $20.42 | +22.43% | 12 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $1.32 | +127.27% | 14 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $2.80 | +971.43% | 20 | Jan 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.18 | - | 10 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $500 | $2.84 | +17,505.63% | 5 | May 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $58 → $48 | $12.73 | +277.06% | 8 | Apr 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $19 | $110.05 | -82.74% | 2 | Feb 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.86 | - | 2 | Apr 16, 2020 |
Lipocine
Jan 21, 2026
Maintains: Buy
Price Target: $7 → $15
Current: $10.91
Upside: +37.49%
Virax Biolabs Group
Jan 9, 2026
Reiterates: Buy
Price Target: $3 → $1
Current: $0.26
Upside: +279.79%
Greenwich LifeSciences
Dec 30, 2025
Maintains: Buy
Price Target: $39 → $50
Current: $25.47
Upside: +96.31%
BioLife Solutions
Dec 29, 2025
Reiterates: Buy
Price Target: $32
Current: $24.87
Upside: +28.67%
Lexaria Bioscience
Dec 26, 2025
Maintains: Buy
Price Target: $4 → $1.5
Current: $0.85
Upside: +76.47%
HeartBeam
Dec 10, 2025
Maintains: Buy
Price Target: $2.5 → $5.5
Current: $1.81
Upside: +203.87%
Ocular Therapeutix
Dec 8, 2025
Maintains: Buy
Price Target: $19 → $21
Current: $10.27
Upside: +104.48%
Axogen
Dec 5, 2025
Maintains: Buy
Price Target: $26 → $39
Current: $32.83
Upside: +18.79%
Belite Bio
Dec 1, 2025
Maintains: Buy
Price Target: $98 → $185
Current: $164.58
Upside: +12.41%
Bionano Genomics
Nov 24, 2025
Maintains: Buy
Price Target: $11 → $7
Current: $1.62
Upside: +332.10%
Nov 24, 2025
Reiterates: Buy
Price Target: $9
Current: $6.99
Upside: +28.76%
Nov 19, 2025
Maintains: Buy
Price Target: $13 → $9
Current: $3.58
Upside: +151.40%
Nov 17, 2025
Maintains: Buy
Price Target: $2.5 → $1.5
Current: $0.28
Upside: +431.91%
Nov 17, 2025
Initiates: Buy
Price Target: $7
Current: $1.77
Upside: +295.48%
Nov 17, 2025
Maintains: Buy
Price Target: $3 → $4
Current: $0.72
Upside: +454.79%
Nov 14, 2025
Maintains: Buy
Price Target: $54 → $36
Current: $21.75
Upside: +65.52%
Nov 12, 2025
Maintains: Buy
Price Target: $64 → $69
Current: $44.47
Upside: +55.16%
Nov 11, 2025
Maintains: Buy
Price Target: $36 → $42
Current: $27.15
Upside: +54.70%
Nov 7, 2025
Maintains: Buy
Price Target: $98 → $89
Current: $65.32
Upside: +36.25%
Nov 3, 2025
Reiterates: Buy
Price Target: $5
Current: $1.45
Upside: +244.83%
Oct 31, 2025
Maintains: Buy
Price Target: $16 → $17
Current: $16.98
Upside: +0.12%
Oct 7, 2025
Maintains: Buy
Price Target: $2 → $2.5
Current: $0.64
Upside: +288.20%
Oct 7, 2025
Reiterates: Buy
Price Target: $34
Current: $13.79
Upside: +146.56%
Sep 29, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.61
Upside: -
Sep 23, 2025
Reiterates: Buy
Price Target: $7
Current: $2.22
Upside: +215.32%
Sep 11, 2025
Reiterates: Buy
Price Target: $7
Current: $3.26
Upside: +114.72%
Sep 4, 2025
Maintains: Buy
Price Target: $12 → $10
Current: $4.04
Upside: +147.52%
Sep 2, 2025
Reiterates: Buy
Price Target: $10
Current: $2.12
Upside: +371.70%
Sep 2, 2025
Reiterates: Buy
Price Target: $4
Current: $1.48
Upside: +170.27%
Sep 2, 2025
Reiterates: Buy
Price Target: $9
Current: $2.14
Upside: +320.56%
Aug 12, 2025
Maintains: Buy
Price Target: $12 → $8
Current: $4.83
Upside: +65.63%
Aug 6, 2025
Maintains: Buy
Price Target: $22 → $23
Current: $15.18
Upside: +51.52%
Jul 16, 2025
Reiterates: Buy
Price Target: $16
Current: $10.38
Upside: +54.14%
May 28, 2025
Initiates: Buy
Price Target: $18
Current: $16.70
Upside: +7.78%
May 5, 2025
Reiterates: Neutral
Price Target: $25
Current: $20.42
Upside: +22.43%
Apr 7, 2025
Reiterates: Buy
Price Target: $3
Current: $1.32
Upside: +127.27%
Jan 2, 2025
Reiterates: Buy
Price Target: $30
Current: $2.80
Upside: +971.43%
Nov 25, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.18
Upside: -
May 17, 2024
Reiterates: Buy
Price Target: $500
Current: $2.84
Upside: +17,505.63%
Apr 22, 2022
Maintains: Neutral
Price Target: $58 → $48
Current: $12.73
Upside: +277.06%
Feb 17, 2021
Maintains: Buy
Price Target: $18 → $19
Current: $110.05
Upside: -82.74%
Apr 16, 2020
Downgrades: Neutral
Price Target: n/a
Current: $0.86
Upside: -